IL-9 activates innate immune cells like mast cells, contributing to tumor growth prevention [38], and in addition to Th9 cell-derived IL-3, induction of adaptive anti-cancer responses that favor DCs survival has been reported in various cancers [39]. This evidence concerns the gene IL3 and neoplasm.